Home � Products & Services � Benchmarking Reports � Medical Affairs � Launch Optimization

Building More Effective Medical Affairs Product Launch Teams: Hematology Segment

Download FREE Excerpt

ID: POP-387

Features:

12 Info Graphics

32 Data Graphics

650+ Metrics

18 Narratives

Pages: 56

Published: 2024

Delivery Format: Shipped

License Options:
$6000 - 1 user
$18000 - Up to 5 users
$30000 - Up to 20 users

Buy Now

919-403-0251

Schedule a Meeting

STUDY OVERVIEW
BENCHMARK CLASS
STUDY SNAPSHOT
KEY FINDINGS
VIEW TOC AND LIST OF EXHIBITS

As hematology treatments proliferate, the strategic involvement of Medical Affairs is crucial for successful product launches. Organizations are now integrating medical expertise earlier in the product lifecycle, leading to more cohesive and agile launch strategies. This approach not only enhances stakeholder engagement but also helps organizations preempt challenges and streamline market entry.

Best Practices, LLC conducted this benchmarking research to explore the evolving role of Medical Affairs in hematology product launches. The report examines shifting roles and responsibilities, cross-functional alignment, performance metrics, resourcing, activity effectiveness, launch timelines, and the deployment of digital tools within the hematology therapeutic area. The report also identifies critical success factors and challenges that are vital for achieving launch excellence in this field.

Industries Profiled:
Biopharmaceutical; Pharmaceutical; Academic; Research; Biotech; Chemical; Consulting; Consumer Products; Health Care; Medical Device

Companies Profiled:
Apellis Pharmaceuticals; ASC Therapeutics; AstraZeneca; Duke University and Health System; Eurofarma; Genentech; Helsinn; Kyowa Kirin; MEDiSTRAVA; Novartis; Pixacore; Sandoz; Takeda Pharmaceuticals; Terumo BCT: Terumo Blood and Cell Technologies

Study Snapshot

Best Practices, LLC engaged 17 Medical leaders from 14 leading life sciences companies in this benchmarking research study. Medical Directors and upper management executives represent nearly four-fifths of the leaders who shared data and insights on Medical launch activities in this study.

Key topics covered in this report include:

Medical Leadership Roles and Launch Activity Effectiveness in Hematology
Ensuring Cross-functional Alignment and Collaboration in Hematology Launches
Medical Launch Evolution in Hematology Segment
Hematology Launch Activities Timeline, Performance Tracking, and Resourcing
Critical Success Factors and Major Pitfalls for Medical Affairs During Hematology Launches
Digital Launch Implementation and Impact in Hematology
Launch Tool Deployment for Hematology Products

Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.

Medical Leadership Roles: Internal disease training and medical strategy are launch priorities consistently led by Medical Affairs.

Launch Challenges: Poor cross-functional alignment and delayed involvement in launch activities are common pitfalls for Medical Affairs during launch.

Table of Contents

Sr. No.	Topic	Slide No.
I.	Executive Summary	Pg. 4
II.	Section I: Launch Excellence and Medical’s Role & Activity Effectiveness	Pg. 6-12
III.	Section II: Ensuring Cross-functional Alignment and Collaboration	Pg. 13-15
IV.	Section III: Adopting to Ongoing Changes in Medical Landscape	Pg. 16-20
V.	Section IV: Launch Timeline, Preparedness Metrics, and Resourcing	Pg. 21-26
VI.	Section V: Critical Success Factors and Major Pitfalls	Pg. 27-32
VII.	Section VI: Digital Influence on Launch Processes and Launch Tool Deployment	Pg. 33-41
VIII.	Section VII: Participant Demographics	Pg. 42-43
IX.	Section VIII: Detailed Benchmark Study Data	Pg. 44-55
X.	Section IX: About Best Practices, LLC	Pg. 56

List of Charts & Exhibits

I. Launch Excellence and Medical’s Role & Activity Effectiveness

Medical launch excellence framework
Medical Affairs’ role in hematology launches
Medical leadership roles in hematology launches
Medical Affairs’ effectiveness in hematology launch activities
Most effective launch activities for Medical Affairs in hematology
Improvement opportunities for Medical Affairs around hematology launch activities

II. Ensuring Cross-functional Alignment and Collaboration

Medical Affairs’ work with internal colleagues to ensure successful hematology launches
Role of Medical Affairs group in cross-functional hematology launch teams

III. Adopting to Ongoing Changes in Medical Landscape

Change fronts for Medical launch evolution
Medical Affairs’ launch evolution around digital data dissemination and communication
Medical Affairs’ launch evolution around medical education
Medical Affairs’ launch evolution around organizational support

IV. Launch Timeline, Preparedness Metrics and Resourcing

Medical Affairs’ hematology launch activities timeline
Total annual Medical Affairs launch investment in U.S. dollars and number of FTEs for hematology products during each of the years in launch phase
Launch dashboard and information used with the dashboard for hematology
Percentage of total Medical Affairs launch investment allocated to each of the listed Medical Affairs activities in hematology
Percentage of total Medical Affairs launch FTEs allocated to each of the listed Medical Affairs activities in hematology

V. Critical Success Factors and Major Pitfalls

Critical success factors for Medical Affairs in hematology launches
Areas where advanced team planning is key for hematology launches
Six critical areas for successful Medical Affairs launch readiness in hematology
Major pitfalls for Medical Affairs during hematology launches
Six major challenge areas for Medical Affairs during hematology launches

VI. Digital Influence on Launch Processes and Launch Tool Deployment

Post-pandemic digital technology utilization in Medical Affairs during hematology product launches
Impact of digital technologies on current and future hematology launch processes
Digital launch tool deployment and impact
Impact of top three digital activities that Medical leads in hematology
Impact of digital activities and programs used to support a successful hematology product launch
Top digital tools that can bring success to Medical Affairs product launch activities
Fast-growing digital tools that are impacting Medicals’ launch strategy
Example of a valuable digital tool that supports launch activities

VII. Participant Demographics

Geographic responsibility of benchmark partners

VIII. Detailed Benchmark Study Data

Role served by Medical Affairs in hematology product launches
Medical Affairs’ launch role effectiveness in hematology
Role served by Medical Affairs in planning, research, and education activities in hematology segment
Role served by Medical Affairs in data dissemination and organizational support activities in hematology segment
Role served by Medical Affairs in research activities in hematology segment
Role served by Medical Affairs in education and data dissemination support activities in hematology segment
Role served by Medical Affairs in organizational support activities in hematology segment
Medical Affairs launch activity involvement timeline - Evidence generation and field-based medical activities in hematology
Medical Affairs launch activity involvement timeline - Medical information and medical regulatory activities in hematology
Medical Affairs launch activity involvement timeline - HEOR activities and medical / scientific communications in hematology
Medical Affairs launch activity involvement timeline - Independent medical education and external engagement activities in hematology